Anti-convulsant potential of quinazolinones

A series of novel quinazoline derivatives were synthesized, virtually screened through different filters and evaluated for their anticonvulsant activity against electrically and chemically induced seizures, compared with that of the standard drugs methaqualone and sodium valproate. Compound 48, 3-(2-aminophenyl)-7-chloro-2-phenylquinazolin-4(3H)-one, was found to be the most potent compound of the series accompanied by relatively low neurotoxicity and low toxicity in the median lethal dose test as compared with the reference drugs. The obtained results showed that compounds 12, 48, 49 and 50 could be useful templates for future design, optimization, and investigation to construct more active analogs.

[1]  Hany E. A. Ahmed,et al.  Design, synthesis, and biological evaluation studies of novel quinazolinone derivatives as anticonvulsant agents , 2013, Medicinal Chemistry Research.

[2]  M. Noolvi,et al.  Synthesis, method optimization, anticancer activity of 2,3,7-trisubstituted Quinazoline derivatives and targeting EGFR-tyrosine kinase by rational approach: 1st Cancer Update , 2013 .

[3]  Ghada S. Hassan,et al.  Novel 4(3H)-quinazolinone analogs: synthesis and anticonvulsant activity , 2013, Medicinal Chemistry Research.

[4]  H. Patel,et al.  Quinazolino-benzothiazoles: fused pharmacophores as anticonvulsant agents. , 2012, European journal of medicinal chemistry.

[5]  V. Alagarsamy,et al.  Design, synthesis and anticonvulsant activities of novel 1-(substituted/unsubstituted benzylidene)-4-(4-(6,8-dibromo-2-(methyl/phenyl)-4-oxoquinazolin-3(4H)-yl)phenyl) semicarbazide derivatives. , 2012, Bioorganic & medicinal chemistry letters.

[6]  A. El-Azab,et al.  Design and synthesis of novel 7-aminoquinazoline derivatives: antitumor and anticonvulsant activities. , 2012, Bioorganic & medicinal chemistry letters.

[7]  Adel S El-Azab,et al.  Synthesis and anticonvulsant evaluation of some new 2,3,8-trisubstituted-4(3H)-quinazoline derivatives. , 2012, Bioorganic & medicinal chemistry letters.

[8]  A. El-Azab,et al.  Design, synthesis and anticonvulsant evaluation of novel 8-substituted-4(3H)-quinazolines , 2011, Medicinal Chemistry Research.

[9]  S. Attia,et al.  Synthesis and anticonvulsant evaluation of some novel 4(3H)-quinazolinones , 2011 .

[10]  J. Stables,et al.  Design, synthesis and potential 6 Hz psychomotor seizure test activity of some novel 2-(substituted)-3-{[substituted]amino}quinazolin-4(3H)-one. , 2011, European journal of medicinal chemistry.

[11]  E. Donner,et al.  New generation anticonvulsants for the treatment of epilepsy in children , 2006, NeuroRX.

[12]  Nikhil D. Amnerkar,et al.  Synthesis, anticonvulsant activity and 3D-QSAR study of some prop-2-eneamido and 1-acetyl-pyrazolin derivatives of aminobenzothiazole. , 2010, European journal of medicinal chemistry.

[13]  Alessandro Pedretti,et al.  Assessing drug-likeness--what are we missing? , 2008, Drug discovery today.

[14]  V. Poroikov,et al.  PASS: identification of probable targets and mechanisms of toxicity , 2007, SAR and QSAR in environmental research.

[15]  H. Stefan,et al.  Novel anticonvulsant drugs. , 2007, Pharmacology & therapeutics.

[16]  W. Löscher,et al.  New horizons in the development of antiepileptic drugs: Innovative strategies , 2006, Epilepsy Research.

[17]  Dieter Schmidt,et al.  New horizons in the development of antiepileptic drugs , 2002, Epilepsy Research.

[18]  P. Selzer,et al.  Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.

[19]  R. Greenwood,et al.  Adverse Effects of Antiepileptic Drugs , 2000, Epilepsia.

[20]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[21]  J. F. Wolfe,et al.  Synthesis and anticonvulsant activity of some new 2-substituted 3-aryl-4(3H)-quinazolinones. , 1990, Journal of medicinal chemistry.

[22]  F. Wilcoxon,et al.  A simplified method of evaluating dose-effect experiments. , 1948, The Journal of pharmacology and experimental therapeutics.